Clin Oncol | Volume 4, Issue 1 | Case Report | Open Access

Papillary Thyroid Carcinoma Development after Radioactive Iodine Treatment for Toxic Adenoma

El Bez I*, Ben Sellem D, Bannour S, Mhiric A and Slim I

Nuclear Medicine Service, Institute Salah Azaïz, Tunisia

*Correspondance to: Intidhar EL BEZ 

Fulltext PDF

Abstract

There are limited reports about malignancy after 131I therapy for thyrotoxicosis. In this report, a case with papillary carcinoma is detected three years after radioactive iodine (RAI) therapy for toxic thyroid nodule. The fine needle aspiration biopsy (FNAB) had not been done before RAI therapy and. The patient underwent bilateral total thyroidectomy and central neck dissection. Physician should think that differentiated thyroid cancer can be found incidentally in toxic nodule or can be developed as a consequence of radioiodine therapy. FNAB must be performed for all the patients with hot or cold thyroid nodules before RAI therapy and all the patients taking RAI therapy should be closely followed in terms of nodule growing and cancer development.

Keywords:

Thyroid cancer; 131I therapy; Toxic adenoma

Citation:

El Bez I, Ben Sellem D, Bannour S, Mhiric A, Slim I. Papillary Thyroid Carcinoma Development after Radioactive Iodine Treatment for Toxic Adenoma. Clin Oncol. 2019; 4: 1585.

Subscribe to Our Newsletter